Jim Cramer on the actual marijuana performs on a Democratic sweep

Jim Cramer on the actual marijuana performs on a Democratic sweep

Follow the picks and shovels performs or the vertically built-in operators that are actually successful, the “Angry Cash” host mentioned. Subscribe to CNBC PRO for rep admission to to investor…

Green Thumb Industries talks U.S. cannabis market, social equity program

Green Thumb Industries talks U.S. cannabis market, social equity program

Green Thumb CEO Ben Kovler mentioned an absence in cannabis crops in some states east and defined Robin Hood CEO Wes Moore’s work on the board. For entry to are…

Green Thumb Industries CEO: ‘Credentializing’ Hashish | Mad Cash | CNBC

Green Thumb Industries CEO: ‘Credentializing’ Hashish | Mad Cash | CNBC

The total cannabis cohort has been smoking sizzling, however no longer all pot shares are created equal. Jim Cramer checks in with the CEO of development-focused Green Thumb Industries to…

GrowGeneration CEO seeks ‘more tough’ cannabis licensing

GrowGeneration CEO seeks ‘more tough’ cannabis licensing

GrowGeneration CEO and co-founder Darren Lampert joined CNBC’s Jim Cramer on Tuesday’s episode of “Angry Money,” explaining why he used to be optimistic on cannabis licensing at some stage in…

Hydrofarm CEO on how the cannabis industry will evolve

Hydrofarm CEO on how the cannabis industry will evolve

Hydrofarm CEO Invoice Toler outlined why the agriculture equipment maker expects most marijuana grow operations will happen indoors as an different of originate air. Subscribe to CNBC PRO for entry…

GrowGeneration talks soar-to-soar expansion plans for cannabis develop store

GrowGeneration talks soar-to-soar expansion plans for cannabis develop store

After opening 26 areas in the previous six months, GrowGeneration CEO Darren Lampert talked about the firm is centered on opening stores on the East Fade. Subscribe to CNBC PRO…

Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC

Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC

It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…